Vimarsana
Biggest News Aggregation in the World

Comprehensive Brain Tumor Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Comprehensive Brain Tumor Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Comprehensive Brain Tumor Program Today - Breaking & Trending Today

'Out of this world': Man plays guitar while undergoing brain surgery at Sylvester Comprehensive Cancer Center - WSVN 7News | Miami News, Weather, Sports - Vimarsana News

'Out of this world': Man plays guitar while undergoing brain surgery at Sylvester Comprehensive Cancer Center - WSVN 7News | Miami News, Weather, Sports

CORAL GABLES, FLA. (WSVN) - A professional guitar player is making news for undergoing brain surgery at a South Florida hospital while playing his guitar<a class="excerpt-read-more" href="https://wsvn.com/news/local/miami-dade/out-of-this-world-man-plays-guitar-while-undergoing-brain-surgery-at-sylvester-comprehensive-cancer-center/">Read More</a>

Source: wsvn.com
ERC-USA Announces FDA Recommendation for Early Termination of Phase 2 Clinical Trial of ERC1671 ... - Vimarsana News

ERC-USA Announces FDA Recommendation for Early Termination of Phase 2 Clinical Trial of ERC1671 ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ERC-USA Announces FDA Recommendation for Early Termination of Phase 2 Clinical Trial of ERC1671 ... ERC-USAApril 7, 2021 GMT IRVINE, Calif., April 07, 2021 (GLOBE NEWSWIRE) -- ERC-USA and the University of California, Irvine (UCI), today announce that the FDA has recommended early termination of the onging Phase 2 clinical trial titled ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma in a letter dated April 2, 2021 ( https://clinicaltrials.gov/ct2/show/NCT01903330?term=Bota&draw=2&r...

Source: apnews.com
Investegate |ERC-USA Announcements | ERC-USA: ERC-USA Announces FDA Recommendation for Early Termination of Phase 2 Clinical Trial of ERC1671 (Gliovac or Sitoiganap) and Application for Registration Trial for Treatment of Glioblastoma - Vimarsana News

Investegate |ERC-USA Announcements | ERC-USA: ERC-USA Announces FDA Recommendation for Early Termination of Phase 2 Clinical Trial of ERC1671 (Gliovac or Sitoiganap) and Application for Registration Trial for Treatment of Glioblastoma

ERC-USA ERC-USA Announces FDA Recommendation for Early Termination of Phase 2 Clinical Trial of ERC1671 (Gliovac or Sitoiganap) and Application for Registration Trial for Treatment of Glioblastoma ERC-USA Announces FDA Recommendation for Early Termination of Phase 2 Clinical Trial of ERC1671 (Gliovac or Sitoiganap) and Application for Registration Trial for Treatment of Glioblastoma IRVINE, Calif., April 07, 2021 (GLOBE NEWSWIRE) -- ERC-USA and the University of California, Irvine (UCI), today announce that the FDA has recommended early termination of the onging Phase 2 clinical trial title...